Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Africa, aggressive, andpreviously, ArQule, ascribed, aspect, Bayer, Bernd, binary, Biopharma, Brian, cooperative, Cortex, CYCC, Cyclacel, cytotoxic, discount, encompassing, endemic, EPO, excercisable, expiry, feedback, fellowship, Forty, foundation, fundamental, FY, Haddassah, homeostatic, house, Huang, IMOH, interdisciplinary, IP, LEO, LifeSci, LSAQ, Mehta, Mereo, mode, Mount, MREO, orchestrate, pandemic, paradigm, payroll, prepapre, Pretoria, prudent, reaction, recession, recuperation, reprogram, reprogrammed, reprogramming, resale, Resetting, respirator, SAB, Schwartz, shelter, shift, sorafenib, spanning, top, Toronto, transform, true, underserved, vertical, Wainwright, wave, ZIO, Ziopharm
Removed:
administering, ascending, Assistant, attestation, began, biologic, biology, Blast, capable, CMS, compensated, complication, concentrated, defer, diagnostic, directing, diversity, Division, elimination, emerging, enrolled, enrollment, eventually, expiring, gastrointestinal, hour, inclusive, inherited, methodology, Microbiology, Modernization, occurrence, ORPN, pathophysiological, rebate, relation, relocation, secondary, simultaneously, society, stay, toxicity, tract, typical, waive
Filing tables
Filing exhibits
- 20-F Annual report (foreign)
- 4.24 Amendment, Dated As of Effective As of January 1, 2020, to the Consulting Agreement by and Between Enlivex Therapeutics, LTD. and A.s. Novik LTD
- 8.1 List of Subsidiaries of Enlivex Therapeutics LTD
- 12.1 Certification
- 12.2 Certification
- 13.1 Certification
- 13.2 Certification
- 15.1 Consent of Consent of Yarel + Partners
- Download Excel data file
- View Excel data file
ENLV similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in the Registration Statement on Form F-3 (Registration No. 333-232413) and the Registration Statements on Form S-8 (Registration No. 333-203114 and 333-210459) of Enlivex Therapeutics Ltd. of our report dated April 20, 2021 with respect to the consolidated financial statements and the effectiveness of internal control over financial reporting of Enlivex Therapeutics Ltd. included in this Annual Report on Form 20-F of Enlivex Therapeutics Ltd. for the year ended December 31, 2020 filed with the Securities and Exchange Commission.
Yarel + Partners
/s/ Yarel + Partners
Tel- Aviv, Israel
April 30, 2021